» Articles » PMID: 24455420

Adipose Tissue in Obesity-related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines

Overview
Journal ISRN Inflamm
Date 2014 Jan 24
PMID 24455420
Citations 487
Authors
Affiliations
Soon will be listed here.
Abstract

Adipose tissue is a complex organ that comprises a wide range of cell types with diverse energy storage, metabolic regulation, and neuroendocrine and immune functions. Because it contains various immune cells, either adaptive (B and T lymphocytes; such as regulatory T cells) or innate (mostly macrophages and, more recently identified, myeloid-derived suppressor cells), the adipose tissue is now considered as a bona fide immune organ, at the cross-road between metabolism and immunity. Adipose tissue disorders, such as those encountered in obesity and lipodystrophy, cause alterations to adipose tissue distribution and function with broad effects on cytokine, chemokine, and hormone expression, on lipid storage, and on the composition of adipose-resident immune cell populations. The resulting changes appear to induce profound consequences for basal systemic inflammation and insulin sensitivity. The purpose of this review is to synthesize the current literature on adipose cell composition remodeling in obesity, which shows how adipose-resident immune cells regulate inflammation and insulin resistance-notably through cytokine and chemokine secretion-and highlights major research questions in the field.

Citing Articles

Do Lifestyle Interventions Mitigate the Oxidative Damage and Inflammation Induced by Obesity in the Testis?.

Moreira R, Oliveira P, Spadella M, Ferreira R, Alves M Antioxidants (Basel). 2025; 14(2).

PMID: 40002337 PMC: 11851673. DOI: 10.3390/antiox14020150.


Association of body roundness index with cardiovascular disease in patients with cardiometabolic syndrome: a cross-sectional study based on NHANES 2009-2018.

He X, Zhu J, Liang W, Yang X, Ning W, Zhao Z Front Endocrinol (Lausanne). 2025; 16:1524352.

PMID: 39963283 PMC: 11830584. DOI: 10.3389/fendo.2025.1524352.


Islet-on-a-chip for the study of pancreatic β-cell function.

Rodriguez-Comas J, Ramon-Azcon J In Vitro Model. 2025; 1(1):41-57.

PMID: 39872972 PMC: 11749753. DOI: 10.1007/s44164-021-00005-6.


Circulating visfatin concentrations in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis.

Aboutaleb N, Moradi A, Mirshekari Jahangiri H, Aslani M Front Med (Lausanne). 2025; 11():1432025.

PMID: 39845836 PMC: 11752917. DOI: 10.3389/fmed.2024.1432025.


Evaluation of Selected Pro- and Anti-Inflammatory Adipokines in Colostrum from Mothers with Gestational Diabetes Mellitus.

Lis-Kuberka J, Berghausen-Mazur M, Orczyk-Pawilowicz M Int J Mol Sci. 2025; 26(1.

PMID: 39795898 PMC: 11719563. DOI: 10.3390/ijms26010040.


References
1.
Fisher J . Potential Role of the AMP-activated Protein Kinase in Regulation of Insulin Action. Cellscience. 2007; 2(3):68-81. PMC: 2099311. View

2.
Fried S, Bunkin D, Greenberg A . Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998; 83(3):847-50. DOI: 10.1210/jcem.83.3.4660. View

3.
Shojaei F, Ferrara N . Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. Drug Resist Updat. 2008; 11(6):219-30. DOI: 10.1016/j.drup.2008.09.001. View

4.
Feve B, Bastard J . The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009; 5(6):305-11. DOI: 10.1038/nrendo.2009.62. View

5.
Zhuang G, Meng C, Guo X, Cheruku P, Shi L, Xu H . A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation. 2012; 125(23):2892-903. DOI: 10.1161/CIRCULATIONAHA.111.087817. View